Canterbury DHB

Context

MDS

In This Section

Standard Allografts

RIC SCTs

Standard Allografts

This is performed following either:

RIC SCTs

Fludarabine/Melphalan/Alemtuzumab is the preferred conditioning for RIC SCT in MDS.

About this Canterbury DHB document (9172):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

December 2016

Next Review:

December 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9172